Quick Answer
Kodiak Sciences Inc. reported Stockholders Equity of $157.38 million for the year ending 2025.
- Kodiak Sciences Inc. showed an increase of +4.7% in Stockholders Equity from 2024 to 2025.
- This data is from Kodiak Sciences Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$77.57 million | Q2 2018: -$84.23 million | Q3 2018: -$93.83 million | Q1 2019: $80.10 million | Q2 2019: $70.02 million | Q3 2019: $59.69 million | Q1 2020: $327.69 million | Q2 2020: $309.20 million | Q3 2020: $281.78 million | Q1 2021: $821.68 million | Q2 2021: $779.43 million | Q3 2021: $726.32 million | Q1 2022: $597.38 million | Q2 2022: $530.93 million | Q3 2022: $479.53 million | Q1 2023: $392.59 million | Q2 2023: $338.48 million | Q3 2023: $302.42 million | Q1 2024: $241.19 million | Q2 2024: $214.51 million | Q3 2024: $185.37 million | Q1 2025: $108.84 million | Q2 2025: $70.29 million | Q3 2025: $23.69 million.
- Over the full 11 years of available data (2015 to 2025), Kodiak Sciences Inc.'s Stockholders Equity has grown by 749.4%.
- Historical annual values: Fiscal year 2025: $157.38 million | Fiscal year 2024: $150.29 million | Fiscal year 2023: $265.78 million | Fiscal year 2022: $436.17 million | Fiscal year 2021: $663.32 million | Fiscal year 2020: $860.75 million | Fiscal year 2019: $345.36 million | Fiscal year 2018: $86.83 million | Fiscal year 2017: -$68.74 million | Fiscal year 2016: -$41.08 million | Fiscal year 2015: -$24.24 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: